IBB

Recent Articles

Biotech Stocks 101 — What Investors Need to Know

This interview with a managing director of Laidlaw offers strategic insights for biotech stock investors. More 

Put Some of Your Accumulated Cash To Work

The S&P 500 has penetrated overhead resistance with a fresh buy signal. More 

Biotech is the Best Buy in This Market

Bargain hunters should focus on biotechs since momentum is clearly on their side. More 

If You’ve Got Trading Discipline, Now’s the Time to Exercise It

This market is overvalued, and we're approaching a historically difficult time for stocks. You can stay long, but stay cautious, too. More 

Major Breakout Occurring While Public Cries Wolf

The S&P 500 continues to reach new heights in the face of investor disbelief. More 

The Most Important Chart to Watch Right Now

Small caps hold the key to the future direction of the broader market. More 

The Growth Game Is Done — It’s Time for Value Stocks

It's probably time to consider shifting your assets into safer classes as value stocks break out of their five-year trend, continuing the outperformance of growth. More